// App-Quantinova.ai

2449 : Hedgehog pathway inhibition sensitizes embryonal rhabdomyosarcoma to standard chemotherapy

Researchers

Presenter

  • Gabriele Manzella

Principal Investigators

  • Tina Kottarathil

  • Beat W. Schaefer

Medical Centers

  • University Childrens Hospital, Zurich, Switzerland

Locations

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Rhabdomyosarcoma

  • Mismatch repair deficiency

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved